Stephanie joined the Anaveon team from a Swiss clinical stage oncology start up, where she was the Head of Corporate Affairs & Human Resources. Previously, she held management positions with increasing responsibilities in investment advisory, strategy development and sales & marketing. She has experience across various industries and geographic regions and is passionate about entrepreneurship and organizational development. Stephanie holds an MBA from IE Business School, Madrid.
- Anaveon presents clinical trial OMNIA-2 at the American Society of Clinical Oncology 2023 Annual MeetingJune 5, 2023
- Anaveon Presents Trial in Progress Data for OMNIA-1 at the American Society of Clinical Oncology 2023 Annual MeetingJune 3, 2023
- Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual MeetingApril 18, 2023